Advertisement
Screener

ROCKWELL MEDICAL, INC. (RMTI) Available-for-sale Securities, Gross Realized Gain (Loss)

ROCKWELL MEDICAL, INC. Available-for-sale Securities, Gross Realized Gain (Loss)

ROCKWELL MEDICAL, INC. (RMTI) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $29.20 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-09.

Discontinued › Income Statement › Other Income

us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2012-11-09

  • ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2012-09-30 was $29.20K.
  • ROCKWELL MEDICAL, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2012-06-30 was $0.00.
Period endAvailable-for-sale Securities, Gross Realized Gain (Loss) 3 monthAvailable-for-sale Securities, Gross Realized Gain (Loss) 6 monthAvailable-for-sale Securities, Gross Realized Gain (Loss) 9 month
2012-09-30$29.20K
10-Q · filed 2012-11-09
$29.20K
derived: sum of 2 quarters · filed 2012-11-09
$29.20K
10-Q · filed 2012-11-09
2012-06-30$0.00
10-Q · filed 2012-08-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
BriaCell Therapeutics Corp. (BCTX)$0.037B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
PMGC Holdings Inc. (ELAB)United States$0.037B
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
NANOVIRICIDES, INC. (NNVC)United States$0.031B